Endothelium-dependent vasorelaxation is inhibited byin vivodepletion of vascular thiol levels: Role of endothelial nitric oxide synthase
- 1 January 2001
- journal article
- Published by Taylor & Francis in Free Radical Research
- Vol. 35 (4) , 387-394
- https://doi.org/10.1080/10715760100300901
Abstract
Thiols like glutathione may serve as reducing cofactors in the production of nitric oxide (NO) and protect NO from inactivation by radical oxygen species. Depletion of thiol compounds reduces NO-mediated vascular effects in vitro and in vivo. The mechanisms underlying these actions are not clear, but may involve decreased synthesis of NO and/or increased degradation of NO. This study investigates the effect of glutathione depletion on the response to NO-mediated vasodilation induced by acetylcholine (Ach, 10 micrograms/kg), endothelial NO synthase (eNOS) activity and potential markers of vascular superoxide anion (O2.-) production in conscious chronically catheterized rats. Thiol depletion induced by buthionine sulfoximine (BSO, 1 g i.p. within 24 h) decreased the hypotensive effect of Ach by 30% (MAP reduction before BSO 27 +/- 3 mmHg, 19 +/- 3 mmHg after BSO, (mean +/- SEM), p < .05, n = 8). The impaired effect of Ach was associated with a significant reduction in eNOS activity (control: 7.7 +/- 0.8, BSO: 3.9 +/- 0.4 pmol/min/mg protein (p < .05), n = 6). In contrast, neither NADH/NADPH driven membrane-associated oxidases nor lucigenin reductase activity were significantly (p < .05) affected by BSO (BSO: 4415 +/- 123, control: 4105 +/- 455 counts/mg; n = 6) in rat aorta. It is concluded that in vivo thiol depletion results in endothelial dysfunction and a reduced receptor-mediated vascular relaxation. This effect is caused by reduced endothelial NO formation.Keywords
This publication has 25 references indexed in Scilit:
- Intracoronary infusion of reduced glutathione improves endothelial vasomotor response to acetylcholine in human coronary circulation.Circulation, 1998
- L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease.Journal of Clinical Investigation, 1998
- Nitric oxide synthesis is impaired in glutathione-depleted human umbilical vein endothelial cellsAmerican Journal of Physiology-Cell Physiology, 1993
- Biochemistry of Nitric Oxide and Its Redox-Activated FormsScience, 1992
- The potent vasodilating and guanylyl cyclase activating dinitrosyl‐iron(II) complex is stored in a protein‐bound form in vascular tissue and is released by thiolsFEBS Letters, 1991
- Endogenous nitric oxide: physiology, pathology and clinical relevanceEuropean Journal of Clinical Investigation, 1991
- Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells.Proceedings of the National Academy of Sciences, 1991
- Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxideNature, 1990
- S‐nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide‐containing vasodilatorsBritish Journal of Pharmacology, 1989
- Eicosonoid metabolism and beta-adrenergic mechanisms in coronary arterial smooth muscle: potential compartmentation of cAMPAmerican Journal of Physiology-Cell Physiology, 1986